VS
iShares Genomics Immunology and Healthcare Index ETF (XDNA) and BMO Equal Weight Banks Index ETF (ZEB) offer distinct profiles for Canadian ETF investors. A direct comparison shows that XDNA focuses its top 3 sector exposures on Healthcare, while ZEB leans towards Finance. When evaluating costs, XDNA features a management fee (MER) of 0.39%, compared to 0.25% for ZEB. Performance-wise, XDNA has returned 50.65% year-to-date with +$6 M in net flows, whereas ZEB is at 30.31% with +$523 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
XDNA
ZEB
| AuM | $15.36 M | $7,409.30 M |
| Management Fees | 0.39% | 0.25% |
| Exp. ratio | 0.44% | 0.28% |
| Tracking Difference | -1.01% | -0.54% |
Historical performance and flows
As of September 8, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | XDNA | +9.92% | +33.63% | +50.65% | +72.37% | +82.86% |
ZEB | -2.15% | +7.09% | +30.31% | +51.91% | +162.10% | |
| Flows | XDNA | +$3 M | +$5 M | +$6 M | +$6 M | +$6 M |
ZEB | +$265 M | +$1,614 M | +$523 M | +$1,028 M | -$355 M |
XDNA vs ZEB exposure
Countries
XDNA
USA
60.39%
Germany
8.55%
France
7.33%
Other
23.74%
ZEB
Canada
100.00%
Sectors
XDNA
Healthcare
99.82%
ZEB
Finance
100.00%
As of September 8, 2026
Top 10 Holdings
XDNA
Bayer AG
4.77%
Twist Bioscience Corp.
4.73%
Revolution Medicines, Inc.
4.61%
Moderna, Inc.
4.37%
Incyte Corp.
4.30%
Takeda Pharmaceutical Co., Ltd.
4.19%
Regeneron Pharmaceuticals, Inc.
4.16%
Genmab A/S
4.12%
Vertex Pharmaceuticals, Inc.
3.86%
Merck & Co., Inc.
3.85%
ZEB
Royal Bank of Canada
17.39%
Bank of Montreal
17.03%
The Toronto-Dominion Bank
16.96%
The Bank of Nova Scotia
16.51%
Canadian Imperial Bank of Commerce
16.09%
National Bank of Canada
16.03%
Diversification
XDNA
Total weight of top 10 holdings out of 47 total
42.96%
ZEB
Total weight of top 10 holdings out of 6 total
100.00%
Characteristics
Compare
XDNA
ZEB
| Provider | iShares | BMO |
| Management | Passively managed | Passively managed |
| Benchmark | NYSE FactSet Global Genomics and Immuno Biopharma NR Index - CAD | Solactive Equal Weight Canada Banks GTR Index - CAD |
| Replication Method | Direct (Physical) | Direct (Physical) |
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.21% | 2.35% |
| Meets ESG criteria | No | No |
| Inception Date | April 26, 2022 | October 20, 2009 |
Frequently asked questions about XDNA and ZEB
Which ETF has performed better year to date: XDNA or ZEB?
As of September 8, 2026, XDNA has returned 50.65% year to date, while ZEB has returned 30.31%. XDNA is ahead on YTD performance.
Which ETF is larger by assets under management: XDNA or ZEB?
As of September 8, 2026, XDNA manages $15.36 M in assets, while ZEB manages $7.41 B. ZEB is the larger fund by AUM.
How are XDNA and ZEB managed?
XDNA is passively managed by iShares. It tracks the NYSE FactSet Global Genomics and Immuno Biopharma NR Index - CAD benchmark. ZEB is passively managed by BMO. It tracks the Solactive Equal Weight Canada Banks GTR Index - CAD benchmark.
What sectors do XDNA and ZEB emphasize?
XDNA is most exposed to Healthcare. ZEB is most exposed to Finance.
Which ETF is attracting more investor flows: XDNA or ZEB?
Year to date, XDNA has seen +$6.43 M in net flows, compared with +$523.03 M for ZEB. ZEB has attracted more net investor money so far.
How do the fees of XDNA and ZEB compare?
XDNA has an expense ratio of 0.44%, while ZEB has an expense ratio of 0.28%.
What are the top holdings of XDNA and ZEB?
XDNA's largest holdings include Bayer AG, Twist Bioscience Corp., and Revolution Medicines, Inc.. ZEB's top holdings include Royal Bank of Canada, Bank of Montreal, and The Toronto-Dominion Bank.
Which ETF is more diversified: XDNA or ZEB?
XDNA holds 47 securities, while ZEB holds 6. On holdings count, XDNA is the more diversified portfolio.
Recent articles about XDNA and ZEB
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.